Genetic, Microbiological and Behavioral Factors in Obesity
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorJan Kochanowski University
About this trial
This study will assess the impact of genetic markers, microbiological (microbiome) and behavioral factors on tolerance, adherence and effectiveness of dual GLP1/GIP RA in the treatment of obesity.
200 consecutive patients who meet all inclusion and none of the exclusion criteria will be enrolled.
Eligibility criteria
Qualifiers
Age 18-60 years
Consent to participate in the study and providing informed written consent
Overweight or obese with a BMI >27
Disqualifiers
Type 1 or type 2 diabetes
Pregnancy or breastfeeding
Cancer
Heart failure
Trial design
Treatments tested in this trial
- genetic polymorphism
- gut microbiome
Treatment groups
200 Participants
are divided into 1 treatment groupSponsors and collaborators
Jan Kochanowski University
Lead sponsor
LUX MED Group
Collaborator
Source ClinicalTrials.gov